Actinium Pharmaceuticals, Inc. Quarterly Nonoperating Income (Expense) in USD from Q4 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Actinium Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q4 2011 to Q2 2024.
  • Actinium Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $1.07M, a 131% increase year-over-year.
  • Actinium Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $4.09M, a 107% increase year-over-year.
  • Actinium Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $3.1M, a 185% increase from 2022.
  • Actinium Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $1.09M, a 472% increase from 2021.
  • Actinium Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was $190K, a 6.74% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $4.09M $1.07M +$604K +131% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $3.48M $927K +$380K +69.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-26
Q4 2023 $3.1M $1.02M +$375K +58.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 $2.73M $1.08M +$750K +231% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $1.98M $461K +$378K +455% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 $1.6M $547K +$512K +1463% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-26
Q4 2022 $1.09M $644K +$606K +1595% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 $481K $325K +$279K +607% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $202K $83K +$29K +53.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $173K $35K -$17K -32.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $190K $38K -$17K -30.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $207K $46K -$27K -37% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $234K $54K +$17K +45.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $217K $52K +$39K +300% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $178K $55K +$24K +77.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-25
Q3 2020 $154K $73K +$20K +37.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $134K $37K -$22K -37.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $156K $13K -$16K -55.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $172K $31K -$12.8K -29.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $185K $53K +$3.82K +7.77% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-23
Q2 2019 $181K $59K +$8.97K +17.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $172K $29K -$1.34K -4.42% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-30
Q4 2018 $173K $43.8K +$20.00 +0.05% Oct 1, 2018 Dec 31, 2018 10-K 2020-05-08
Q3 2018 $173K $49.2K -$323K -86.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $496K $50K -$99.6K -66.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $596K $30.3K +$286K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $310K $43.8K -$87.3K -66.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q3 2017 $397K $372K -$130K -25.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $527K $150K -$144K -49.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $671K -$256K -$1.85M -116% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $2.53M $131K +$1.75M Oct 1, 2016 Dec 31, 2016 10-K 2019-03-15
Q3 2016 $774K $502K -$192K -27.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 $966K $294K +$353K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 $613K $1.6M -$3.19M -66.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $3.8M -$1.62M -$3.07M -212% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-16
Q3 2015 $6.87M $694K -$274K -28.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-28
Q2 2015 $7.15M -$59.2K -$8M -101% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-29
Q1 2015 $15.1M $4.79M +$17.4M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$2.21M $1.45M +$5.84M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 -$8.05M $968K +$780K +415% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-30
Q2 2014 -$8.83M $7.94M +$9.25M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$18.1M -$12.6M -$13.9M -1042% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 -$4.18M -$4.4M -$5.22M -632% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-11
Q3 2013 $1.04M $188K +$801K Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-31
Q2 2013 $238K -$1.31M -$585K -80.9% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 $824K $1.33M +$1.24M +1284% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 -$414K $826K +$827K Oct 1, 2012 Dec 31, 2012 10-K 2014-02-28
Q3 2012 -$1.24M -$613K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$723K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-13
Q1 2012 $96.4K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$1.33K Oct 1, 2011 Dec 31, 2011 10-Q 2012-04-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.